Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Amber L. Collier"'
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 6, Iss , Pp 100165- (2022)
The prognosis of advanced/metastatic GISTs has improved significantly through treatment with a combination of neoadjuvant and/or adjuvant imatinib, a tyrosine kinase inhibitor, and surgical resection. However, GISTs often show variable response to ne
Externí odkaz:
https://doaj.org/article/4685a7f45c00428ea5d92c4dca0f2c85
Autor:
Ifeanyichukwu Ogobuiro, Amber L. Collier, Khadeja Khan, Iago de Castro Silva, Deukwoo Kwon, Gregory C. Wilson, Patrick B. Schwartz, Alexander A. Parikh, Chet Hammill, Hong J. Kim, David A. Kooby, Daniel Abbott, Shishir K. Maithel, Rebecca A. Snyder, Syed A. Ahmad, Nipun B. Merchant, Jashodeep Datta
Publikováno v:
Annals of Surgical Oncology. 30:1485-1494
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32ef8577f707cd95eb87c5745cefca9d
https://doi.org/10.1245/s10434-022-12741-4
https://doi.org/10.1245/s10434-022-12741-4
Autor:
Ankit M Shah, Dayana Perez-Sanchez, Amber L. Collier, Joshua P. Kronenfeld, Christina I. Lee, Neha Goel, Seraphina Choi
Publikováno v:
Journal of Surgical Oncology
Background The coronavirus (COVID‐19) pandemic led to disruptions in operative and hospital capabilities as the country triaged resources and canceled elective procedures. This study details the operative experience of a safety‐net hospital for c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3cee0fafe6675a1ca6bd7b319bfe560
https://doi.org/10.1002/jso.26616
https://doi.org/10.1002/jso.26616
Autor:
Ifeanyichukwu Ogobuiro, Amber L. Collier, Khadeja Khan, Iago de Castro Silva, Deukwoo Kwon, Gregory C. Wilson, Patrick B. Schwartz, Alexander A. Parikh, Chet Hammill, Hong J. Kim, David A. Kooby, Daniel Abbott, Shishir K. Maithel, Rebecca A. Snyder, Syed A. Ahmad, Nipun B. Merchant, Jashodeep Datta
Publikováno v:
Annals of Surgical Oncology. 30:1498-1499
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f858c6f10d804388c91ce0f4a5a849c3
https://doi.org/10.1245/s10434-022-12912-3
https://doi.org/10.1245/s10434-022-12912-3
Autor:
Mecker G. Möller, Dido Franceschi, Steve Rodgers, Eli Avisar, Kristin N. Kelly, Amber L. Collier, Neha Goel, Susan B. Kesmodel, Sina Yadegarynia
Publikováno v:
Journal of Surgical Oncology. 124:25-32
Purpose Utilization of sentinel lymph node biopsy (SLNB) in breast cancer patients with positive nodes after neoadjuvant chemotherapy (NAC) has increased. We examine axillary response rates after NAC in patients with clinical N2-3 disease to determin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bad8f81e350826fa6a447d7a8f0f79
https://doi.org/10.1002/jso.26480
https://doi.org/10.1002/jso.26480
Autor:
Francis I. Macedo, Kristin N. Kelly, Amber L. Collier, Brianna L. Cohen, Dido Franceschi, Eli Avisar, Danny Yakoub, Neha Goel, Mecker G. Möller, Susan B. Kesmodel
Publikováno v:
Annals of Surgical Oncology. 27:1830-1841
Occult breast cancer (OBC) is a rare clinical entity. Current surgical management includes axillary lymphadenectomy (ALND) with or without mastectomy. We sought to investigate the role of sentinel lymph node biopsy (SLNB) in patients with OBC treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06b2d7eaa9ef0309662462cbc99475d2
https://doi.org/10.1245/s10434-020-08227-w
https://doi.org/10.1245/s10434-020-08227-w
Autor:
Nipun B. Merchant, Ann Y. Lee, Manuel Fernandez, Annie Wang, Joshua P. Kronenfeld, Amber L. Collier, Harry M. Richter, Matthew R. Porembka, Michelle R. Ju, Jashodeep Datta, Maria C. Russell, Michael K. Turgeon, Ajay V. Maker, Rodrigo E. Alterio
Publikováno v:
J Surg Oncol
Journal of surgical oncology, vol 124, iss 8
Journal of surgical oncology, vol 124, iss 8
BACKGROUND Neoadjuvant chemotherapy (NAC) is standard management for localized gastric cancer (GC). Attrition during NAC due to treatment-related toxicity or functional decline is considered a surrogate for worse biologic outcomes; however, data supp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3947830979bd701fb17eca17d6ab2417
https://europepmc.org/articles/PMC8595640/
https://europepmc.org/articles/PMC8595640/
Autor:
Billur Samli, Lauren L. Siewertsz van Reesema, David Z. Chang, Harry D. Bear, Janet S. Winston, Amber L. Collier, Amy H. Tang, Matthew P. Goetz, Richard A. Hoefer, Emanuel F. Petricoin, Rick J. Jansen, Gagan K. Gupta, Vasilena Zheleva, Mary L. Guye, Dasom Lee, Angela M. Tang-Tan
Publikováno v:
Cancers, Vol 12, Iss 2392, p 2392 (2020)
Cancers
Cancers
Triple-negative breast cancer (TNBC), characterized by the absence or low expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2), is the most aggressive subtype of breast cancer. TNBC accou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cd226ef9ec6343eaecc188a948e8eb3
https://www.mdpi.com/2072-6694/12/9/2392
https://www.mdpi.com/2072-6694/12/9/2392
Autor:
Dido Franceschi, Alan S. Livingstone, Amber L. Collier, Joshua P. Kronenfeld, Chad M. Thorson, Danny Sleeman
Publikováno v:
Journal of the American College of Surgeons. 233:S141
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d95c70dc8578c5b647d40e25703c167d
https://doi.org/10.1016/j.jamcollsurg.2021.07.275
https://doi.org/10.1016/j.jamcollsurg.2021.07.275
Autor:
Alan S. Livingstone, Dido Franceschi, Amber L. Collier, Shayan Khalafi, Danny Sleeman, Joshua P. Kronenfeld, Chad M. Thorson
Publikováno v:
Journal of the American College of Surgeons. 233:S119
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b4af6d7c5eda285d5642c7988fd7a48
https://doi.org/10.1016/j.jamcollsurg.2021.07.229
https://doi.org/10.1016/j.jamcollsurg.2021.07.229